Quick Hits: FDA Approves Drugs for Tardive Dyskinesia, Hep C; Sedatives and Pneumonia Risk

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

The FDA approved Ingrezza (valbenazine) to treat adults with tardive dyskinesia, a serious side effect characterized by involuntary movements in the face and extremities sometimes seen in patients who have been treated with antipsychotic medications. Ingrezza, the first drug approved for this condition, may itself cause unwanted side effects such as sleepiness and heart rhythm problems (QT prolongation). Patients with congenital long QT syndrome (abnormal heartbeat) should avoid taking this drug. Posted April 11, 2017. Via FDA.

The FDA has approved 2 hepatitis C (HCV) drugs, Sovaldi and Harvoni, for use in children ages 12 to 17. Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) are the first direct-acting antiviral treatments approved for children and adolescents with HCV. Some patients experienced reactivation of the hepatitis B virus (HBV) when treated with the drugs, resulting in serious liver problems or death. The FDA advises that all healthcare professionals screen all of their patients for evidence of current or prior HBV infection before starting treatment with Harvoni or Sovaldi. Posted April 7, 2017. Via FDA.

Sedatives such as Valium or Xanax may increase the risk for pneumonia in Alzheimer’s patients. Researchers reviewed data from nearly 50,000 Alzheimer’s patients in Finland. The patients’ average age was 80 and about two-thirds were women. The study, published in the CMAJ (Canadian Medical Association Journal), found that people with Alzheimer’s who took benzodiazepines were 30% more likely to develop pneumonia than those who weren’t given the sedatives. Posted April 10, 2017. Via CMAJ.


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement